{"id":25471,"date":"2018-04-19T09:41:47","date_gmt":"2018-04-19T17:41:47","guid":{"rendered":"http:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/04\/19\/fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment\/"},"modified":"2018-04-19T12:58:17","modified_gmt":"2018-04-19T20:58:17","slug":"fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/04\/19\/fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment\/","title":{"rendered":"FDA advisory panel gives thumbs-up to CBD epilepsy treatment"},"content":{"rendered":"<\/p>\n<p>A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don\u2019t respond to other drugs. The panel voted [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment\/\">FDA advisory panel gives thumbs-up to CBD epilepsy treatment<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment\/\" target=\"_blank\">FDA advisory panel gives thumbs-up to CBD epilepsy treatment<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don\u2019t respond to<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/04\/19\/fda-advisory-panel-gives-thumbs-up-to-cbd-epilepsy-treatment\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":39,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,3156,3157,2043,2313],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/25471"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=25471"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/25471\/revisions"}],"predecessor-version":[{"id":25472,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/25471\/revisions\/25472"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=25471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=25471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=25471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}